Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 10, 2024

BUY
$1.15 - $2.19 $5,750 - $10,950
5,000 Added 50.0%
15,000 $22,000
Q4 2023

Feb 07, 2024

BUY
$0.93 - $2.35 $9,300 - $23,500
10,000 New
10,000 $21,000
Q3 2021

Oct 29, 2021

SELL
$16.69 - $26.05 $25,035 - $39,075
-1,500 Closed
0 $0
Q1 2021

May 11, 2021

BUY
$20.71 - $51.02 $12,426 - $30,612
600 Added 66.67%
1,500 $37,000
Q4 2020

Feb 05, 2021

BUY
$21.84 - $44.0 $19,656 - $39,600
900 New
900 $33,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $171M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Banque Cantonale Vaudoise Portfolio

Follow Banque Cantonale Vaudoise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.